Comparison Between India, EU & US Regulatory Requirements

This comparison highlights the key regulatory differences between India, EU, and US medical device regulations. As healthcare technology expands globally, understanding India, EU, and US medical device regulations is essential for successful product submissions and market access.

Regulatory Framework Overview

• India: Governed by Central Drugs Standard Control Organization under Medical Device Rules (MDR) 2017

• EU: Regulated under MDR by the European Commission with Notified Bodies

• US: Regulated by the U.S. Food and Drug Administration (FDA)

Key Differences

• Classification

  • India: Class A, B, C, D

  • EU: Class I, IIa, IIb, III

  • US: Class I, II, III

• Authorized Representative

  • India: Authorized Indian Agent

  • EU: European Authorized Representative

  • US: US Agent

• Quality Management System

  • India & EU: ISO 13485:2016

  • US: 21 CFR Part 820

• UDI Requirement

  • Mandatory in all three regions

• Post-Market Surveillance (PMS)

  • India & EU: Required for all classes

  • US: Primarily for Class II and III

• Clinical Data

  • Accepted in all regions; high-risk devices may require local studies

Navigating India, EU, and US medical device regulations requires understanding differences in classification, QMS, audits, and post-market obligations. A region-specific regulatory strategy is essential for efficient global market entry and sustained compliance.